Sanchez, Kate B.
HRN: 29-19-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2026
AMPICILLIN 1GM (VIAL)
07/28/2026
07/29/2026
IV
2gms
Q6hrs
Thickly MSAF
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: